International Scholarly Research Notices / 2011 / Article / Tab 4 / Clinical Study
Meibomian Gland Dysfunction: Endocrine Aspects Table 4 Descriptive statistics of serum hormone levels with respect to genders disclosing statistically significant differences of mean values between patients with seborrheic meibomian gland dysfunction and controls.
Controls mean (SD) Patients mean (SD) P values (95% CI)Controls and patients mean (SD) All gender Testosterone (ng/ml) 2.27 (2.72) 4.78 (3.67) P = 0.000 (1.22, 3.79)3.52 (3.45) DHEA-S (μ g/ml) 238.50 (97.70) 370.70 (146.50) P = 0.000 (82.78, 181.63)304.60 (140.60) Female TSH (μ IU/mL) 1.64 (0.89) 2.46 (1.40) P = 0.014 (0.17, 1.48)1.95 (1.17) Prolactin (ng/ml) 17.79 (7.45) 23.51 (12.00) P = 0.043 (0.19, 11.24)19.97 (9.74) Testosterone (ng/ml) 0.37 (0.16) 0.69 (0.08) P = 0.001 (0.15, 0.49)0.49 (0.29) DHEA-S (μ g/ml) 212.07 (86.32) 325.57 (141.78) P = 0.001 (48.80, 178.19) 255.20 (122.70) Male Testosterone (ng/ml) 5.38 (1.91) 7.28 (2.20) P = 0.003 (0.68, 3.14)6.56 (2.28) DHEA-S (μ g/ml) 281.60 (102.0) 398.40 (144.60) P = 0.003 (40.42, 193.07)354.0 (141.10)
CI: confidence interval, DHEA-S: dihydroepiandrosterone-sulphate, TSH: thyroid stimulating hormone, SD: standard deviation.